- Home
- CELU vs BEDU Comparison
CELU vs BEDU Comparison
Compare CELU & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- BEDU
- Stock Information
- Founded
- CELU 2016
- BEDU 1994
- Country
- CELU United States
- BEDU United Kingdom
- Employees
- CELU N/A
- BEDU N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- BEDU Other Consumer Services
- Sector
- CELU Health Care
- BEDU Real Estate
- Exchange
- CELU Nasdaq
- BEDU Nasdaq
- Market Cap
- CELU 42.2M
- BEDU 44.9M
- IPO Year
- CELU N/A
- BEDU 2017
- Fundamental
- Price
- CELU $1.61
- BEDU $1.57
- Analyst Decision
- CELU
- BEDU
- Analyst Count
- CELU 0
- BEDU 0
- Target Price
- CELU N/A
- BEDU N/A
- AVG Volume (30 Days)
- CELU 54.8K
- BEDU 15.8K
- Earning Date
- CELU 12-06-2024
- BEDU 05-06-2025
- Dividend Yield
- CELU N/A
- BEDU N/A
- EPS Growth
- CELU N/A
- BEDU N/A
- EPS
- CELU N/A
- BEDU N/A
- Revenue
- CELU $48,200,000.00
- BEDU $231,461,038.00
- Revenue This Year
- CELU N/A
- BEDU N/A
- Revenue Next Year
- CELU $233.89
- BEDU N/A
- P/E Ratio
- CELU N/A
- BEDU N/A
- Revenue Growth
- CELU 225.94
- BEDU N/A
- 52 Week Low
- CELU $1.00
- BEDU $1.35
- 52 Week High
- CELU $5.22
- BEDU $2.42
- Technical
- Relative Strength Index (RSI)
- CELU 49.49
- BEDU 46.22
- Support Level
- CELU $1.47
- BEDU $1.47
- Resistance Level
- CELU $1.77
- BEDU $1.74
- Average True Range (ATR)
- CELU 0.16
- BEDU 0.17
- MACD
- CELU 0.01
- BEDU -0.01
- Stochastic Oscillator
- CELU 63.04
- BEDU 15.87
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.